Medical Device Investing Salix Supports CMS Announcement of First ICD-10 Code for Hepatic Encephalopathy
Bristol Myers Squibb and 2seventy bio Announce Topline Results from KarMMa-3 Trial Showing Abecma Significantly Improves Progression-Free Survival Versus Standard Regimens in Relapsed and Refractory Multiple Myeloma
Medical Device Investing Johnson & Johnson to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
Gilead Sciences and a Coalition of LGBTQ+ and Human Rights-Focused Organizations Mobilize to Address Monkeypox Public Health Emergency
Life Science Investing CORRECTING and REPLACING Cybin Announces Up to USD$35 Million At-The-Market Equity Program
Medical Device Investing Mathai Mammen, M.D., Ph.D., Leaves Position as Executive Vice President, Pharmaceuticals, R&D, Johnson & Johnson
Life Science Investing Cybin Inc. Reports First Quarter Financial Results and Recent Business Highlights
Pharmaceutical Investing Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15
Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee
